PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20, Chazhong Road, Fuzhou, 350005, Fujian, China.\', \'Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20, Chazhong Road, Fuzhou, 350005, Fujian, China. xiexianhe@fjmu.edu.cn.\', \'Fujian Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China. xiexianhe@fjmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12885-022-09320-x
?:hasPublicationType
?:journal
  • BMC cancer
is ?:pmid of
?:pmid
?:pmid
  • 35246063
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.464
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all